GROUPAMA ASSET MANAGMENT

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1055969 PARIS, I0

Position in REGN

as of Mar 31, 2026 · filed May 22, 2026 Compact

Position Value

$54,936,249

-$7,001 QoQ

Shares Held

71,102

-0.1% QoQ

Ownership

0.068%

of shares outstanding

% of Portfolio

0.80%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 85.34499732778262.ToString("F0")% Shared 0.ToString("F0")% None 14.655002672217377.ToString("F0")%

Healthcare · as of Mar 31, 2026

GROUPAMA ASSET MANAGMENT holds $249,620,066 across 10 Biotechnology names. REGN ranks #3 (22.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	165,897	$74,079,646
2	IONS	Ionis Pharmaceuticals Inc	824,540	$61,914,708
3	REGN	Regeneron Pharmaceuticals, Inc. This page	71,102	$54,936,249
4	MDGL	Madrigal Pharmaceuticals, Inc.	35,238	$18,446,035
5	BNTX	BioNTech SE	185,036	$16,445,999
6	ALNY	Alnylam Pharmaceuticals, Inc.	36,767	$12,165,097
7	INCY	Incyte Corp	66,451	$6,254,368
8	DNLI	Denali Therapeutics Inc.	207,130	$3,976,896

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$54,936,249	71,102	-0.1%	Shares	Sole	2026-05-22
2025-12-31	$54,943,250	71,182	+13.5%	Shares	Sole	2026-02-27
2025-09-30	$35,254,891	62,701	-7.6%	Shares	Sole	2025-12-01
2025-06-30	$35,631,750	67,870	-25.1%	Shares	Sole	2025-08-13
2025-03-31	$57,468,848	90,612	+12.8%	Shares	Sole	2025-05-14
2024-12-31	$57,227,879	80,339	+12.7%	Shares	Sole	2025-02-12
2024-09-30	$74,929,233	71,277	+7.0%	Shares	Sole	2024-11-15
2024-06-30	$70,029,077	66,629	+32.7%	Shares	Sole	2024-08-14
2024-03-31	$48,328,547	50,212	-25.5%	Shares	Sole	2024-05-14
2023-12-31	$59,171,275	67,371	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.